Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases

Tocilizumab has been recognized as one of the few existing biologic useful for combating COVID-19 infections especially in critically ill patient. We had experience in treating five critically ill patients with severe lung injury who were COVID-19 positive with tocilizumab. In the present case serie...

Descripción completa

Detalles Bibliográficos
Autores principales: ElSeirafi, Mohamed M, Hasan, Hasan MSN, Sridharan, Kannan, Zamoori, Alaa, Alkhawaja, Sana, Pasha, Sheikh Abdul Azeez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308754/
https://www.ncbi.nlm.nih.gov/pubmed/32632355
http://dx.doi.org/10.1016/j.rmcr.2020.101139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308754/
https://www.ncbi.nlm.nih.gov/pubmed/32632355
http://dx.doi.org/10.1016/j.rmcr.2020.101139

Ejemplares similares